PHARMA STOCK DEFENDING AGAINST DOWN MOMENT OF NIFTY

The Indian Stock market started to crash. Pharma stock stood against the down market to defend the down moment of Nifty.

 Indian market is being traded by the appearance Nifty-50 but nifty has broken nearby 30%. As you know when nifty is down the Indian stock market also crashed. But at this moment a stock sector is arising which gives shocking returns to investors who defending against Nifty. Yes Defending against Nifty. The stock is Pharmaceutical industries. if You see the pharmaceutical index of nifty it is performing too pretty at this time. 
Pharmaceutical stocks give approximately 30% return past few months and 18% return the past 6 months.  Pharmaceutical industries performed too well to raise their economic activities. 
https://financegrow.blogspot.com/2020/04/pharma-stock-is-profitable-when-nifty-down

So today we will cover those stocks who defending badly the Nifty to go down.

CIPLA:

Cipla is a pharmaceutical company that is the World's Biggest Antiretroviral manufacturing having Market capitalization 40,000 cr. Cipla operating both Branded, Generic, and API Drugs. Cipla carrying a diversified portfolio. If we see the P/E ratio of CIPLA is 28 which is pretty higher. The Mkt cap is about 483.46.
 If we talk about the return Cipla has gives 50% return past few months. when the market was crashing it arises a new resistance to go down.

DR. Reddy's laboratory: 

 PAST FEW MONTH RETURN: 40%+REVENUE: INR 14,203Cr+ MARKET CAPITALISATION: 663.49Cr+P/E RATIO: 39+   Ind-PE 23+PROFIT MARGIN: 20TRADING: 4000 INR.CONCLUSION:
1 DR. Reddy's lab made 80% generic drugs major in India. If we see the profit Dr. Reddy's made INR 532cr+ However he is saying that he covered 538cr+. Dec 2018 it made 3865cr+ and Dec 2019 made 4397cr+.

2 It always maintains there profit margin in between 17 to 20 quit good signs of future Investment.


CADILA HEALTH CARE:

It is the best stock which affects the index of Nifty.
REVENUE: INR 119.05 Billion 
MARKET CAPITALISATION: 344.64B 
TRADING: 335
P/E RATIO:27.62
CONCLUSION:
1 if we see The profit CADILA was at 11,905 cr+ in 2018 as for financial year close and made 1,849cr+ In 2019 as per financial year close.
So it has maintained pretty good profit margins. 

2 PE ratio is bigger than its industrial PE ratio. 

3 Trading at 335 During the crash market So it may quite a better option to trade it.


Aurobindo Pharma Ltd:

REVENUE:  5000 Cr+                                           
MARKET CAPILAISATON:  365.65 
PROFIT:  52070CR+
P/E:14      ind P/E- 24
PROFIT MARGIN:     20+
TRADING:      627.50 INR

CONCLUSION:

Aurobindo Pharma Ltd has a very low pe value comparison to the industrial pe ratio.
but It can able to maintain their profit margin above the 20. It is now trading at 627. It was crashing a few months but starting rebounding now. It may be a good opportunity for you to step toward this stock.

SUNPHARMA:
                                                                                                                            

REVENUE:  INR 30,091cr+

PROFIT MARGIN:  20%
TRADING:  485.50
MARKET CAPILASATION: 1.16T
P/E: 29.12    IND PE: 24

CONCLUSION:


1  Sun pharma is the world's 5th biggest pharmaceutical company and the first biggest company in India. It manufacturing generic drugs. It was taken over by Ranbaxy later.

2  In 2008 the total revenue was INR. 3000 cr+ but now it became INR 30,091 cr+. It maintains a 29.12 pe ratio which is quite big their industrial pe ration.

3  It has an operating profit margin of 20% which is a pretty appearance. You can use these stocks for the long term to get a handsome return.


so these was the 5 pharma stocks who performed very good toward defending against the down moment of nifty. 


was this helpful please give valuable react to our blog.

Any doubt is annoying you please let our expert kill them. 

Any kind of blog you want never forgets to suggest to us.